Vireo Growth (VREOF) Finished Goods (2020 - 2026)
Vireo Growth's (VREOF) quarterly Finished Goods came in at $31.0 million in Q1 2026, up 385.11% year-on-year from $6.4 million in Q1 2025, and up 58.16% quarter-over-quarter from $19.6 million in Q4 2025.
Vireo Growth (VREOF) Finished Goods (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Finished Goods across 7 years of filings, most recently posting $31.0 million for Q1 2026.
- Finished Goods for Q1 2026 came in at $31.0 million, up 385.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.0 million (up 385.11% YoY), and the FY2025 annual result was $19.6 million, up 230.34% from the prior year.
- Finished Goods came in at $31.0 million for Q1 2026 at Vireo Growth, up from $19.6 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $31.0 million in Q1 2026 to a low of $4.1 million in Q3 2022.
- The 5-year median for Finished Goods is $5.8 million (2024), against an average of $9.3 million.
- Across the five-year window, Finished Goods declined 15.13% in 2022 and surged 385.11% in 2026, its largest moves.
- Vireo Growth's Finished Goods stood at $5.5 million in 2022, then slipped by 4.15% to $5.3 million in 2023, then grew by 12.41% to $5.9 million in 2024, then surged by 230.34% to $19.6 million in 2025, then soared by 58.16% to $31.0 million in 2026.
- The last three Finished Goods figures came in at $31.0 million (Q1 2026), $19.6 million (Q4 2025), and $18.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.00 Mn |
| Dec 31, 2025 | 19.60 Mn |
| Sep 30, 2025 | 18.32 Mn |
| Jun 30, 2025 | 18.64 Mn |
| Mar 31, 2025 | 6.39 Mn |
| Dec 31, 2024 | 5.93 Mn |
| Sep 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 5.91 Mn |
| Mar 31, 2024 | 5.32 Mn |
| Dec 31, 2023 | 5.28 Mn |
| Sep 30, 2023 | 5.48 Mn |
| Jun 30, 2023 | 5.13 Mn |
| Mar 31, 2023 | 5.94 Mn |
| Dec 31, 2022 | 5.51 Mn |
| Sep 30, 2022 | 4.10 Mn |
| Jun 30, 2022 | 4.82 Mn |
| Mar 31, 2022 | 4.66 Mn |
| Dec 31, 2021 | 4.58 Mn |
| Sep 30, 2021 | 4.83 Mn |
| Jun 30, 2021 | 4.53 Mn |